Die Information für Ärzte und Apotheker
Neutral, unabhängig und anzeigenfrei
arznei-telegramm® 04/2016
previous issue next issue
This is a translation of the table of contents. One article is translated and freely available.

THERAPY FROM A CRITICAL VIEWPOINT
Polypill with rosuvastatin, candesartan and hydrochlorothiazide failed for the time being

NEW ON THE MARKET
Mepolizumab (NUCALA) for severe refractory eosinophilic asthma
Brivaracetam (BRIVIACT) against partial-onset seizures

a-t READER'S QUESTIONS AND COMMENTS
Vaccination against tick-borne encephalitis: how often to booster?
Prophylactic antibiotics prior to procedures in patients with prosthetic joints?
Oral g-strophanthin (ouabain) for heart patients?

IN BRIEF
Painkillers against uncomplicated cystitis?
Olmesartan (OLMETEC, VOTUM) is no longer reimbursed in France
Progressive multifocal leukoencephalopathy with dimethyl fumarate (TECFIDERA)

CURRENT ADR NETWORK REPORT
Tinnitus with topical green tea extract (VEREGEN)

SIDE EFFECTS
Abuse of the antihistamines diphenhydramine (e.g. EMESAN) and dimenhydrinate (e.g. VOMEX A)  free article 
© 2020 arznei-telegramm